Dr. Cluck Clinical Application New Antimicrobials EXAM 3 Flashcards
What are the Newer Antibiotics?
-Ceftolozane(5)-tazobactam
-Ceftazidim(3)-avibactam
-Delafloxacin (FQ)
-Vancins: Oritavancin, Dalbavancin
-Tedizolid
What is Delafloxacin FDA-approved for?
Community-acquired bacterial pneumonia (CABP)
What is Ceftolozane-tazobactam FDA-approved for?
-Hospital-acquired bacterial pneumonia (HABP)
-Ventilator-associated bacterial pneumonia (VABP)
Newer Antimicrobial agents
-Plazomicin
-Eravacycline
-Omadacycline
-Imipenem-cilastatin/relebactam
-Lefamulin
-Cefiderocol
How does Plazomicin (Zemdri) achieve stability to
most aminoglycoside modifying enzymes (AMEs)?
Structurally enhanced sisomicin pharmacophore
What is Plazomicin (Zmedri) FDA-approved for?
!!!
Only for complicated urinary tract infections (cUTI)
!!!
The antibacterial approach and way of Elimination for Aminoglycosides?
-Bacteriocidal
-Eliminated through the kidney
MOA of Plazomicin
Inhibits bacterial protein synthesis at the 30S ribosome and is rapidly bactericidal
How are Plazomicin concentrations monitored in patients?
-Through monitoring is acceptable
-in systemic infections: AUC-based dosing is preferred
Which organism is susceptible to Plazomicin?
!!!
-MRSA (but not Strep and Enterococci)!!
-CRE !!!
-ESBL producing Enterobacterales !!!
-Variable activity against New Dehli metallo ß lactamases !!!
What is the Mechanism of Resistance in Plazomicin?
16s ribosomal methyltransferases (16S RMTases) -> decreased affinity to the drug target
Which antimicrobial agent is outdated and should be used?
-Colistin
-bc of its Nephro- and Ototoxicity
-used as Adjunctive in MDR, especially CRE
What is Eravacycline (Xerava) approved for?
-for complicated intra-abdominal infection (cIAI)!!!
-only IV !!
-synthetic fluorocycline
-similar to Tigecycline, but more potent against gram (+) cocci and gram (-) rods
Spectrum of activity for Eravacycline
-similar to Tigecycline
-wide spectrum to Gram(+) and Gram(-) including difficult-to-treat MRSA, VRE, ESBL, and carbapenemase-producers
-NO activity against Pseudomonas
-activity against non-tuberculous mycobacteria and C. diff (so less C. diff with Eravacycline)
MOA for Eravacycline
-similar to other tetracyclines: binding to 30S subunit -> inhibits protein synthesis
-bacteriostatic against many organisms, but has also shown bacteriocidal activity
At what point is Eravacycline different from Tigecycline?
!!!
PK/PD: higher plasma concentration !!!
-> so MIC can be achieved, whereas Tigecycline doesn’t reach MIC for many organisms
-BUT CYP mediated metabolism -> Drug-Drug Interaction !!!
Why is the clinical use for Tigecycline low?
Because of its PK/PD profile
-low plasma concentration -> doesn’t reach MIC
-hence not used for in UTIs and bacteremia